Search the Newsreel

Why Valvoline Is Dropping 5.1%: TD Cowen Maintains Buy

Valvoline Inc. (VVV) shares dropped 5.1% after TD Cowen and RBC Capital trimmed their price targets, signaling reduced near-term upside potential. Despite the price target reductions, both firms maintained Buy-equivalent ratings, suggesting long-term confidence. The market's reaction appears outsized compared to the modest target …

AlTi Global (NASDAQ:ALTI) Issues Quarterly Earnings Results

Alvotech to Report Financial Results for H1 2026

Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company, announced it will release its financial results for the first half of 2026 on Wednesday, August 19, 2026, after the U.S. market close. The company will also host a webcast with a live Q&A on Thursday, …

Alvotech Schedules Live Q&A After Its H1 2026 Results Release

Alvotech (NASDAQ: ALVO) will release its financial results for the first half of 2026 on Wednesday, August 19, 2026, after the U.S. market close. The company will also host a webcast with a live Q&A session on Thursday, August 20, 2026, at 08:00 ET. …

Valvoline Q3 Earnings Call Highlights

Valvoline (VVV) reported strong Q3 fiscal 2026 results, with sales exceeding $1 billion for the first time and adjusted EPS up 21%. The company raised its full-year same-store-sales outlook despite rising lubricant costs due to global oil supply chain disruptions, implementing pricing actions to …

Amundi Acquires Shares of 8,361 Autoliv, Inc. $ALV

Amundi acquired 8,361 shares of Autoliv, Inc. (NYSE:ALV) in the first quarter, valued at approximately $879,000, as other institutional investors also adjusted their positions. Autoliv shows a "Moderate Buy" consensus from analysts with an average price target of $135.93, despite a slight miss on …

Zacks Research Has Weak Estimate for Autoliv FY2026 Earnings

ALTI | AlTi Global, Inc. Class Financials - Income Statement

This page provides financial data and other information for AlTi Global, Inc. (ALTI). It includes sections on income statement, balance sheet, cash flow, institutional holdings, analyst ratings, and insider trading activity, but notes a lack of recent data for many categories. The company is …

Palvella Therapeutics, Inc. $PVLA Shares Purchased by The Manufacturers Life Insurance Company

Is Autoliv (ALV) Undervalued Or Is Its Safety Growth Story Already Priced In?

ALVARIUM TIEDEMANN Q2 2026 Earnings Preview: Recent $ALTI Insider Trading, Hedge Fund Activity, and More

Palvella Therapeutics (PVLA) Earnings And QTORIN Hopes Keep Undervaluation In Focus

Is Palvella Therapeutics (PVLA) Fully Valued Ahead Of QTORIN Approval?

ALVES Hisse Yorumları (ALVES KABLO Güncel Yorumlar)

ALVO: FDA Inspection Closure And Biosimilar Resubmissions Will Drive Upside

Alvotech (ALVO) has seen its fair value reset to $5.75 from $13.83 by analysts, reflecting updated assumptions on growth and profitability, despite recent positive regulatory developments. The FDA closed its inspection of Alvotech's Reykjavik facility with a Voluntary Action Indicated classification, and the company …

Autoliv Inc (ALV) Earnings Forecast: Future EPS & Revenue Growth Estimates

Autoliv Inc (ALV) has an earnings forecast score of 7.80, ranking 26th in the Automobiles & Auto Parts industry, with an average price target of $140.00 from 20 analysts. The stock is predominantly rated as "Buy," with expected revenue of $2.72 billion for the …

Valvoline Inc. (NYSE: VVV) CEO gains 27 deferred stock units

Valvoline Inc. CEO Lori Ann Flees acquired 27 Deferred Stock Units at $35.62 each through salary deferral under the company's 2016 Deferred Compensation Plan. This transaction increases her total holdings to 15,655 deferred units, each representing a contingent right to one share of common …

Valvoline (VVV) Reports Q3 Earnings: What Key Metrics Have to Say

Valvoline (VVV) reported $544.6 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 24.1%. EPS of $0.57 for the same period compares to $0.47 a year ago. The reported revenue represents a surprise of +1.49% over the Zacks Consensus …

Palvella Therapeutics, Inc. (NASDAQ:PVLA) Receives Consensus Rating of "Buy" from Analysts

Palvella Therapeutics, Inc. (NASDAQ:PVLA) has received a consensus "Buy" rating from analysts, with an average 12-month price target of $209.14, significantly above its current trading price of $154.93. Despite this positive sentiment, the company recently reported quarterly losses of $1.52 per share, missing consensus …

Earnings Call: Allianz SE übertrifft Q2-Prognosen, Aktie gibt dennoch nach

Palvella Therapeutics Inc (PVLA) Earnings Forecast: Future EPS & Revenue Growth Estimates

Vermögensverwaltung treibt Allianz - Zögern bei Prognose

Allianz SE bestätigt Ergebnisprognose für 2026

Earnings Call: Allianz SE meldet Rekordgewinn für H1, Aktie fällt trotz übertroffener Q2-Erwartungen

Balefire LLC Sells 64,456 Shares of Valvoline $VVV

Balefire LLC reduced its stake in Valvoline (NYSE:VVV) by 76.2% in the second quarter, selling 64,456 shares and retaining 20,120 shares valued at approximately $796,000. Despite this reduction, Valvoline's third-quarter results exceeded expectations with adjusted EPS of $0.57 and revenue up 24.1%. Analyst sentiment …

Valvoline (VVV) Stock Dips As Margin Pressure Tempers Strong Sales Growth

RBC Capital Adjusts Price Target on Valvoline to $46 From $47, Maintains Outperform Rating

RBC Capital has adjusted its price target for Valvoline (VVV) to $46 from $47, while reiterating an "Outperform" rating on the stock. This update follows Valvoline's recent Q3 2026 earnings call, where the company reported increased adjusted earnings and revenue. The new price target …

Valvoline (VVV) Beats On Earnings, Is The Pullback A Chance To Buy?

High-Risk Warning for Investors in Palvella Therapeutics Securities

Palvella Therapeutics, Inc. (PVLA) has issued a new risk disclosure in the "Regulation" category, indicating a high degree of risk for potential shareholders. The company urges investors to carefully review its disclosed risks and uncertainties, which could materially impact investment value. Despite these warnings, …

Full Transcript: Palvella Therapeutics Q2 2026 Earnings Call

Palvella Therapeutics reported significant progress in Q2 2026, advancing QTORIN rapamycin with compelling Phase 3 SELVA study results, a pre-NDA meeting with the FDA, and Rolling Review designation. The company is on track to complete the NDA submission for QTORIN rapamycin in 2026, targeting …

Autoliv (NYSE:ALV) Stands Out for Dividend Quality

Valvoline Inc. (NYSE: VVV) lifts 2026 guidance after strong third quarter

Valvoline Inc. reported strong third-quarter 2026 results with a 24% increase in net revenues to $544.6 million and a 16% rise in diluted EPS to $0.51. The company raised its full-year 2026 guidance, expecting system-wide same-store sales growth of 7.5%-8% and net revenues of …

Valvoline Inc (VVV) (Q3 2026) Earnings Call Highlights: Strong Same-Store Sales Growth and ...

This article first appeared on GuruFocus. Release Date: August 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Valvoline Inc (NYSE:VVV) delivered strong same-store sales growth, driven by increased customer traffic and higher …

Palvella Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PVLA)

Palvella Therapeutics, Inc. (PVLA) published a slide deck in conjunction with their Q2 2026 earnings call, held on August 5, 2026. The company reported an EPS of -$1.52, missing estimates by $0.37, while revenue was $0.00, beating estimates by $0.00. This report was prepared …

18 More Valvoline Service Centers Expected by End-2027

Franchise Equity Partners (FEP) portfolio company, Velocity Auto Care, has reached 50 Valvoline Instant Oil Change service centers, including a new location in Edinburg, Texas. This milestone follows FEP's partnership with Velocity in December 2024 to acquire 38 franchise locations and a seven-year development …

Valvoline Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:VVV)

Valvoline Inc. (NYSE:VVV) has published its Q3 2026 earnings call presentation. The company reported an EPS of $0.57, beating estimates by $0.07, and revenue of $544.60 million, surpassing estimates by $986.47K and showing a 24.05% year-over-year increase. This slide deck accompanies their recent earnings …